Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al
J Thromb Haemost
.
2022 Jan;20(1):270-271.
doi: 10.1111/jth.15578.
Epub 2021 Nov 22.
Authors
Helen Fogarty
1
2
,
Ellie Karampini
1
,
Andrew S O'Donnell
3
,
Soracha E Ward
1
,
Jamie M O'Sullivan
1
,
James S O'Donnell
1
2
4
;
Irish COVID-19 Vasculopathy Study (iCVS) investigators
Affiliations
1
Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
2
National Coagulation Centre, St James's Hospital, Dublin, Ireland.
3
Department of Paediatrics, University Maternity Hospital Limerick, Limerick, Ireland.
4
National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
PMID:
34738307
PMCID:
PMC8646468
DOI:
10.1111/jth.15578
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19* / complications
Endothelial Cells
Humans
Post-Acute COVID-19 Syndrome
SARS-CoV-2